Skip to main content
Erschienen in: Esophagus 2/2016

30.07.2015 | Original Article

Efficacy of lymph node dissection for each station based on esophageal tumor location

verfasst von: Yuji Tachimori, Soji Ozawa, Hodaka Numasaki, Hisahiro Matsubara, Masayuki Shinoda, Yasushi Toh, Harushi Udagawa, Mitsuhiro Fujishiro, Tsuneo Oyama, Takashi Uno, The Registration Committee for Esophageal Cancer of the Japan Esophageal Society

Erschienen in: Esophagus | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

The area of nodal dissection should be modified by the location of the primary tumor in an individual patient. The purpose of this study was to evaluate the efficacy of lymph node dissection based on station by the location of the primary tumor based on a multi-institutional nationwide registry of esophageal cancer.

Methods

The study group comprised 1295 patients who underwent R0 resection and three-field esophagectomy. The Efficacy Index (EI) was calculated by multiplying the incidence of metastases to a station and the 5-year survival rate of patients with metastases to that station, by tumor location.

Results

There were 550 patients without nodal metastases and 745 patients with them. In patients with upper tumors, the EIs of recurrent nerve nodes, cervical paraesophageal nodes and supraclavicular nodes were highest. In patients with middle tumors, the EIs of recurrent nerve nodes, cardiac nodes and lesser curvature nodes were highest, and the EIs of supraclavicular nodes and cervical paraesophageal nodes were not negligible. In patients with lower tumors, the EIs of cardiac nodes, lesser curvature nodes and left gastric artery nodes were highest, and the EIs of recurrent nerve nodes were also high.

Conclusion

The EIs of certain node stations were different by location of the primary tumor. Node stations for dissection should be modified by the location of the primary tumor. For upper and middle esophageal tumors, the three-field approach is recommended. Dissection of the upper mediastinum is recommended for patients with lower esophageal tumors.
Literatur
1.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C, UICC International Union Against. Cancer TNM classification of malignant tumors. 7th ed. New York: Wiley-Blackwell; 2009. Sobin LH, Gospodarowicz MK, Wittekind C, UICC International Union Against. Cancer TNM classification of malignant tumors. 7th ed. New York: Wiley-Blackwell; 2009.
2.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
3.
Zurück zum Zitat Japan Esophageal Society. Japanese classification of esophageal cancer, 10th edition: part I. Esophagus. 2009;6:1–25.CrossRef Japan Esophageal Society. Japanese classification of esophageal cancer, 10th edition: part I. Esophagus. 2009;6:1–25.CrossRef
4.
Zurück zum Zitat Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2001. Esophagus. 2009;6:95–110.CrossRef Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2001. Esophagus. 2009;6:95–110.CrossRef
5.
Zurück zum Zitat Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2002. Esophagus. 2010;7:7–22.CrossRef Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2002. Esophagus. 2010;7:7–22.CrossRef
6.
Zurück zum Zitat Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2003. Esophagus. 2011;8:9–29.CrossRef Ozawa S, Tachimori Y, Baba H, et al. Comprehensive registry of esophageal cancer in Japan, 2003. Esophagus. 2011;8:9–29.CrossRef
7.
Zurück zum Zitat Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82. Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus. 1996;9:173–82.
8.
Zurück zum Zitat Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.CrossRefPubMed Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931–5.CrossRefPubMed
9.
10.
Zurück zum Zitat Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: preface, general principles, part I. Esophagus. 2004;1:61–88. Japanese Society for Esophageal Diseases. Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: preface, general principles, part I. Esophagus. 2004;1:61–88.
11.
Zurück zum Zitat Fujita H, Kakegawa T, Yamana H, et al. Lymph node compartments as guidelines for lymphadenectomy for esophageal carcinoma. Dis Esophagus. 1994;7:169–78. Fujita H, Kakegawa T, Yamana H, et al. Lymph node compartments as guidelines for lymphadenectomy for esophageal carcinoma. Dis Esophagus. 1994;7:169–78.
12.
Zurück zum Zitat Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed Sasako M, McCulloch P, Kinoshita T, et al. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82:346–51.CrossRefPubMed
13.
Zurück zum Zitat Fujita H, Aikou T, Tsurumaru M, et al. A new N category for cancer in the esophagogastric junction based on lymph node compartments. Esophagus. 2007;4:103–10.CrossRef Fujita H, Aikou T, Tsurumaru M, et al. A new N category for cancer in the esophagogastric junction based on lymph node compartments. Esophagus. 2007;4:103–10.CrossRef
14.
Zurück zum Zitat Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–7.CrossRefPubMed Udagawa H, Ueno M, Shinohara H, et al. The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol. 2012;106:742–7.CrossRefPubMed
15.
Zurück zum Zitat Kang CH, Kim YT, Jeon SH, et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007;31:154–60.CrossRefPubMed Kang CH, Kim YT, Jeon SH, et al. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007;31:154–60.CrossRefPubMed
16.
Zurück zum Zitat Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384–93 (discussion 1393–4).CrossRefPubMed Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384–93 (discussion 1393–4).CrossRefPubMed
17.
Zurück zum Zitat Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221–6.CrossRefPubMed Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221–6.CrossRefPubMed
18.
Zurück zum Zitat Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239–46.CrossRefPubMed Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112:1239–46.CrossRefPubMed
19.
Zurück zum Zitat Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549–56.CrossRefPubMed Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549–56.CrossRefPubMed
20.
Zurück zum Zitat Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.CrossRefPubMed Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251:46–50.CrossRefPubMed
22.
Zurück zum Zitat Stiles BM, Nasar A, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. Eur J Cardiothorac Surg. 2012;42:659–64.CrossRefPubMed Stiles BM, Nasar A, Mirza FA, et al. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy. Eur J Cardiothorac Surg. 2012;42:659–64.CrossRefPubMed
23.
Zurück zum Zitat Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33–8.CrossRefPubMed Tachimori Y, Nagai Y, Kanamori N, et al. Pattern of lymph node metastases of esophageal squamous cell carcinoma based on the anatomical lymphatic drainage system. Dis Esophagus. 2011;24:33–8.CrossRefPubMed
24.
Zurück zum Zitat Kuge K, Murakami G, Mizobuchi S, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003;125:1343–9.CrossRefPubMed Kuge K, Murakami G, Mizobuchi S, et al. Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg. 2003;125:1343–9.CrossRefPubMed
Metadaten
Titel
Efficacy of lymph node dissection for each station based on esophageal tumor location
verfasst von
Yuji Tachimori
Soji Ozawa
Hodaka Numasaki
Hisahiro Matsubara
Masayuki Shinoda
Yasushi Toh
Harushi Udagawa
Mitsuhiro Fujishiro
Tsuneo Oyama
Takashi Uno
The Registration Committee for Esophageal Cancer of the Japan Esophageal Society
Publikationsdatum
30.07.2015
Verlag
Springer Japan
Erschienen in
Esophagus / Ausgabe 2/2016
Print ISSN: 1612-9059
Elektronische ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0503-7

Weitere Artikel der Ausgabe 2/2016

Esophagus 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.